Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
Cancer Research
|
July 15, 1988
Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer
C Tondini, D F Hayes, R Gelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1992
Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptor
L Damstrup, J Andersen, D W Kufe, et al.
Seminars in Oncology
|
March 1, 1987
New agents and new medical treatments for advanced breast cancer
I C Henderson, D F Hayes, S Come, et al.
Cancer Research
|
February 15, 1990
Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow
C Tondini, S A Pap, D F Hayes, et al.
The Journal of Clinical Investigation
|
May 1, 1985
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients
D F Hayes, H Sekine, T Ohno, et al.
Cancer Research
|
May 1, 1992
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen
L Perey, D F Hayes, P Maimonis, et al.
Cancer Research
|
May 19, 2001
Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody
C Akewanlop, M Watanabe, B Singh, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 1, 1973
Early endoscopy. A guide to therapy for acute hemorrhage in the upper gastrointestinal tract
C Sugawa, M H Werner, D F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group
C L Shapiro, T Ervin, L Welles, et al.
Breast Cancer Research and Treatment
|
June 16, 1999
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
M Watanabe, P K Wallace, T Keler, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
Cancer Research
|
July 15, 1988
Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer
C Tondini, D F Hayes, R Gelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1992
Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptor
L Damstrup, J Andersen, D W Kufe, et al.
Seminars in Oncology
|
March 1, 1987
New agents and new medical treatments for advanced breast cancer
I C Henderson, D F Hayes, S Come, et al.
Cancer Research
|
February 15, 1990
Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow
C Tondini, S A Pap, D F Hayes, et al.
The Journal of Clinical Investigation
|
May 1, 1985
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients
D F Hayes, H Sekine, T Ohno, et al.
Cancer Research
|
May 1, 1992
Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen
L Perey, D F Hayes, P Maimonis, et al.
Cancer Research
|
May 19, 2001
Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody
C Akewanlop, M Watanabe, B Singh, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
August 1, 1973
Early endoscopy. A guide to therapy for acute hemorrhage in the upper gastrointestinal tract
C Sugawa, M H Werner, D F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group
C L Shapiro, T Ervin, L Welles, et al.
Breast Cancer Research and Treatment
|
June 16, 1999
Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
M Watanabe, P K Wallace, T Keler, et al.
Page
of 14